CAMP logo

CAMP4 Therapeutics (CAMP) Company Overview

Profile

Full Name:

CAMP4 Therapeutics

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

October 11, 2024

Indexes:

Not included

Description:

CalAmp is a technology company that provides solutions for tracking and managing vehicles and assets. They use GPS and wireless communication to help businesses improve efficiency, reduce costs, and enhance safety. Their services are used in various industries, including transportation, logistics, and fleet management.

Events Calendar

Earnings

Next earnings date:

N/A

Recent quarterly earnings:

Jun 27, 2024

Recent annual earnings:

Jun 27, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

Feb 2, 2024

Analyst ratings

Recent major analysts updates

Nov 5, 24 William Blair
Outperform
Nov 5, 24 Piper Sandler
Overweight
Nov 5, 24 Leerink Partners
Outperform
Nov 5, 24 JP Morgan
Overweight
Jan 11, 24 Goldman Sachs
Sell
Oct 9, 23 Goldman Sachs
Sell
Oct 6, 23 Roth MKM
Buy
Oct 6, 23 Craig-Hallum
Hold
Aug 29, 23 Roth MKM
Buy
Jul 13, 23 Goldman Sachs
Sell

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for CAMP4 Therapeutics?
  • Does CAMP4 Therapeutics pay dividends?
  • What sector is CAMP4 Therapeutics in?
  • What industry is CAMP4 Therapeutics in?
  • What country is CAMP4 Therapeutics based in?
  • When did CAMP4 Therapeutics go public?
  • Is CAMP4 Therapeutics in the S&P 500?
  • Is CAMP4 Therapeutics in the NASDAQ 100?
  • Is CAMP4 Therapeutics in the Dow Jones?
  • When was CAMP4 Therapeutics's last earnings report?
  • When does CAMP4 Therapeutics report earnings?
  • Should I buy CAMP4 Therapeutics stock now?

What is the ticker symbol for CAMP4 Therapeutics?

The ticker symbol for CAMP4 Therapeutics is NASDAQ:CAMP

Does CAMP4 Therapeutics pay dividends?

No, CAMP4 Therapeutics does not pay dividends

What sector is CAMP4 Therapeutics in?

CAMP4 Therapeutics is in the Healthcare sector

What industry is CAMP4 Therapeutics in?

CAMP4 Therapeutics is in the Biotechnology industry

What country is CAMP4 Therapeutics based in?

CAMP4 Therapeutics is headquartered in United States

When did CAMP4 Therapeutics go public?

CAMP4 Therapeutics's initial public offering (IPO) was on October 11, 2024

Is CAMP4 Therapeutics in the S&P 500?

No, CAMP4 Therapeutics is not included in the S&P 500 index

Is CAMP4 Therapeutics in the NASDAQ 100?

No, CAMP4 Therapeutics is not included in the NASDAQ 100 index

Is CAMP4 Therapeutics in the Dow Jones?

No, CAMP4 Therapeutics is not included in the Dow Jones index

When was CAMP4 Therapeutics's last earnings report?

CAMP4 Therapeutics's most recent earnings report was on Jun 27, 2024

When does CAMP4 Therapeutics report earnings?

The date for CAMP4 Therapeutics's next earnings report has not been announced yet

Should I buy CAMP4 Therapeutics stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions